Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Burjeel Holdings has entered a partnership with US-based Paige for deploying AI approved by the Food and Drug Administration ...

In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased ...

• Ultra-low PSA Response (<0.02 ng/mL) with Darolutamide Plus ADT in ARANOTE Correlates with Greatly Improved Clinical Outcomes Interactive Poster Session: IP26-07; April 29, 9:30-11:30 a.m. PDT ...

Cambridge found a drug that costs mere pennies per pill could help prevent a type of cancer that kills about four out of five ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Sexual function data support enzalutamide as monotherapy and combined with leuprolide in patients with high-risk biochemically recurrent prostate cancer. Enzalutamide monotherapy maintains sexual ...

Radiotherapy remains a fundamental treatment for prostate cancer, and recent developments in precision medicine and ...

In a Maple Grove industrial strip mall unequipped with the beanbag chairs common to Silicon Valley startups, Francis Medical ...

AstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) citing commercial reasons.